Akoustis Technologies, Inc.
AKTS
$0.5973
-$0.0127-2.08%
Weiss Ratings | AKTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | AKTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Good | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | AKTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 2.64 | |||
Price History | AKTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -12.33% | |||
30-Day Total Return | -23.92% | |||
60-Day Total Return | -62.36% | |||
90-Day Total Return | -73.57% | |||
Year to Date Total Return | -77.74% | |||
1-Year Total Return | -82.89% | |||
2-Year Total Return | -91.10% | |||
3-Year Total Return | -91.84% | |||
5-Year Total Return | -87.38% | |||
52-Week High % Change | -87.69% | |||
52-Week Low % Change | 32.61% | |||
Price | AKTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $4.96 | |||
52-Week Low Price | $0.46 | |||
52-Week Low Price (Date) | Oct 27, 2023 | |||
52-Week High Price (Date) | Feb 08, 2023 | |||
Valuation | AKTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | $44.22M | |||
Enterprise Value | 62.23M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.95 | |||
Earnings Per Share Growth | -19.38% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 1.54 | |||
Price/Book (Q) | 0.65 | |||
Enterprise Value/Revenue (TTM) | 2.18 | |||
Price | $0.62 | |||
Enterprise Value/EBITDA (TTM) | -1.08 | |||
Enterprise Value/EBIT | -0.89 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | AKTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 72.307M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | AKTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 704 997 5735 | |||
Address | 9805 Northcross Center Court Huntersville, NC 28078 | |||
Website | www.akoustis.com | |||
Country | United States | |||
Year Founded | 2013 | |||
Profitability | AKTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -243.91% | |||
Profit Margin | -226.20% | |||
Management Effectiveness | AKTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -32.03% | |||
Return on Equity | -- | |||
Income Statement | AKTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | $28.56M | |||
Total Revenue (TTM) | $28.56M | |||
Revenue Per Share | $0.40 | |||
Gross Profit (TTM) | -$3.31M | |||
EBITDA (TTM) | -$57.83M | |||
EBIT (TTM) | -$69.65M | |||
Net Income (TTM) | -$64.60M | |||
Net Income Avl. to Common (TTM) | -$64.60M | |||
Total Revenue Growth (Q YOY) | 25.80% | |||
Earnings Growth (Q YOY) | -5.44% | |||
EPS Diluted (TTM) | -$0.95 | |||
EPS Diluted Growth (Q YOY) | 16.65% | |||
Balance Sheet | AKTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | $25.79M | |||
Cash Per Share (Q) | $0.36 | |||
Total Current Assets (Q) | $38.58M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | $67.79M | |||
Current Ratio (Q) | 2.427 | |||
Book Value Per Share (Q) | $0.94 | |||
Total Assets (Q) | $127.15M | |||
Total Current Liabilities (Q) | $15.90M | |||
Total Debt (Q) | $43.80M | |||
Total Liabilities (Q) | $59.36M | |||
Total Common Equity (Q) | $67.79M | |||
Cash Flow | AKTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -$24.52M | |||
Cash from Financing (TTM) | $32.59M | |||
Net Change in Cash (TTM) | -$34.88M | |||
Levered Free Cash Flow (TTM) | -$31.52M | |||
Cash from Operations (TTM) | -$42.94M | |||